Clinical Trial Update: Early Oral Intake After Pancreaticoduodenectomy in the Age of ERAS [NA]

View source ↗

Summary

This clinical trial update discusses evaluating early oral intake after pancreaticoduodenectomy within ERAS-era care for resectable periampullary carcinoma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Periampullary Carcinoma

Snippet

Sponsor: Xuzhou Medical University | Conditions: Periampullary Carcinoma Resectable, Pancreaticoduodenectomy | NA | Status: UNKNOWN